Butyric Acid

Butyric Acid

SCHEMBL4741080

CCCC(=O)O.CCCC(=O)O.CCCCCCC(CC)(CCCCCC)C(=O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.52
PPARG P37231 7/20 0.52
PPARD Q03181 7/20 0.52
PPARA Q07869 7/20 0.52
HDAC11 Q96DB2 5/20 0.52
TSHR P16473 4/20 0.52
PTPN1 P18031 3/20 0.52
ALDH1A1 P00352 2/20 0.52
TLR2 O60603 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
FABP4 P15090 2/20 0.52
SLC22A6 Q4U2R8 1/20 0.52
SLC22A8 Q8TCC7 1/20 0.52
MEN1 O00255 1/20 0.52
ESR1 P03372 1/20 0.52
ALOX15 P16050 1/20 0.52
PDE4A P27815 1/20 0.52
KMT2A Q03164 1/20 0.52
PDE3A Q14432 1/20 0.52
HSD17B10 Q99714 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL4901036 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
Butyric Acid SCHEMBL3043683 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
Butyric Acid SCHEMBL6923796 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
Butyric Acid SCHEMBL2817305 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
Butyric Acid SCHEMBL5479989 0.95 GPR84 (0.47) GPR84PPARGPPARDPPARAHDAC11
Butyric Acid SCHEMBL10452438 0.95 GPR84 (0.47) GPR84PPARGPPARDPPARAHDAC11
Palmitic Acid SCHEMBL30142631 0.93 GPR84 (0.63) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL4900334 0.93 GPR84 (0.57) GPR84PPARGPPARDPPARAHDAC11
Decanoic Acid SCHEMBL9956867 0.93 GPR84 (0.63) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL573131 0.93 GPR84 (0.63) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045836-B1 PYRIDONES AS SRC FAMILY SH2 DOMAIN INHIBITORS BOEHRINGER INGELHEIM PHARMA (US) 2008-03-05 EP disclosed
US-6284768-B1 Src family SH2 domain inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2001-09-04 US disclosed
US-6268365-B1 Src family SH2 domain inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2001-07-31 US disclosed
EP-1045836-A1 PYRIDONES AS SRC FAMILY SH2 DOMAIN INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2000-10-25 EP disclosed
US-6054470-A Src family SH2 domain inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2000-04-25 US disclosed
WO-1999031066-A1 PYRIDONES AS SRC FAMILY SH2 DOMAIN INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1999-06-24 WO disclosed
US-5830863-A NATURALLY OCCURRING NEUROKININ A WITH MODIFIED AMIDE BOND CONNECTING THE TWO AMINO ACIDS ON THE CARBOXY TERMINAL MERRELL PHARMACEUTICALS INC. (US) 1998-11-03 US disclosed
US-5731286-A Cyclic neurokinin A antagonists MERRELL PHARMACEUTICALS, INC. (US) 1998-03-24 US disclosed
EP-0412542-B1 Cyclic neurokinin antagonists MERRELL DOW PHARMA (US) 1996-01-03 EP disclosed
EP-0347802-B1 Neurokinin A antagonists MERRELL DOW PHARMA (US) 1994-06-15 EP disclosed
EP-0412542-A2 Cyclic neurokinin antagonists MERRELL DOW PHARMACEUTICALS INC. (US) 1991-02-13 EP disclosed
EP-0347802-A2 Neurokinin A antagonists MERRELL DOW PHARMACEUTICALS INC. (US) 1989-12-27 EP disclosed